23andMe (ME) shares were up sharply on Thursday after a court authorized the company to start an asset sale process through a Chapter 11 plan or pursuant to Section 363 of the US Bankruptcy Code.
The US Bankruptcy Court for the Eastern District of Missouri also approved the bidding procedures related to the process, the genetics testing company said late Wednesday.
Price: 0.77, Change: +0.24, Percent Change: +45.66
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.